Page last updated: 2024-08-24

dexmedetomidine and Esophageal Squamous Cell Carcinoma

dexmedetomidine has been researched along with Esophageal Squamous Cell Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujisaki, J; Hirasawa, T; Horiuchi, Y; Ishiyama, A; Omae, M; Sano, H; Tsuchida, T; Yamamoto, Y; Yokota, M; Yoshimizu, S; Yoshio, T	1

Trials

1 trial(s) available for dexmedetomidine and Esophageal Squamous Cell Carcinoma

Article	Year
Efficacy of novel sedation using the combination of dexmedetomidine and midazolam during endoscopic submucosal dissection for esophageal squamous cell carcinoma. Esophagus : official journal of the Japan Esophageal Society, 2019, Volume: 16, Issue:3 Topics: Aged; Aged, 80 and over; Anesthesia; Case-Control Studies; Dexmedetomidine; Drug Therapy, Combination; Endoscopic Mucosal Resection; Endoscopy; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Humans; Hypnotics and Sedatives; Japan; Male; Midazolam; Middle Aged; Personal Satisfaction; Prospective Studies; Retrospective Studies; Self Report; Surveys and Questionnaires; Treatment Outcome	2019

Article

Year

Efficacy of novel sedation using the combination of dexmedetomidine and midazolam during endoscopic submucosal dissection for esophageal squamous cell carcinoma.

Esophagus : official journal of the Japan Esophageal Society, 2019, Volume: 16, Issue:3

Topics: Aged; Aged, 80 and over; Anesthesia; Case-Control Studies; Dexmedetomidine; Drug Therapy, Combination; Endoscopic Mucosal Resection; Endoscopy; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Humans; Hypnotics and Sedatives; Japan; Male; Midazolam; Middle Aged; Personal Satisfaction; Prospective Studies; Retrospective Studies; Self Report; Surveys and Questionnaires; Treatment Outcome

2019